id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-303046-unksl7p4	Pawlotsky, Jean-Michel	COVID-19 and the liver-related deaths to come	2020-06-11		.txt	text/plain	1899	78	36	As a result of lockdowns and suspension of usual clinical care activities for the benefit of patients with COVID-19, the SARS-CoV-2 pandemic is having a major effect on the management of patients with chronic liver diseases, in particular those with cirrhosis, hepatocellular carcinoma and in liver transplantation programmes. The COVID-19 pandemic will also negatively affect the care and management of patients with hepatocellular carcinoma, generating delayed diagnosis, deferred treatment (including medical and surgical, such as access to liver transplantation), loss to follow-up and, ultimately, increased mortality. Most COviD-19-induced liver-mortality will be delayed, resulting from deferred care for liver diseases, reduced funding for public health interventions and the global economic crisis, which will lead to increases in alcohol and drug use and in blood-borne virus transmissions, while access to care and funding are reduced.	./cache/cord-303046-unksl7p4.txt	./txt/cord-303046-unksl7p4.txt